PROF. CHRISTOPH WANNER
1. Do you have, or have you had during the past 2 years, any formal association with a company or other interested party?
Consultant for company
Date |
2019- 2020
|
Company or interest group |
Akebia, Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, Chiesi, FMC, Idorsia, Sanofi-Genzyme, Mundipharma, GSK, MSD, Reata, Gilead, Tricida, Vifor
|
Value |
More than EUR 10,000
|
Payment made to |
Personal account
|
2. Do you have, or have you had during the past 2 years, any of the following types of association with a company or other interested party?
Lecturing, chairing lectures or participation in symposia/panel discussions
Date |
2019- 2020
|
Company or interest group |
Amgen, AstraZeneca, Boehringer Ingelheim, FMC, Sanofi-Genzyme, Lilly, Takeda
|
Value |
More than EUR 10,000
|
Payment made to |
Personal account
|
3. Do you have, or have you had during the past 2 years, any job, position, research grant, or other grant that involved a company or other interested party?
Research grant
Date |
2019- 2020
|
Company or interest group |
Idorsia, Genzyme-Sanofi, Shire, Boehringer-Ingelheim
|
Value |
More than EUR 10,000
|
Payment made to |
Hospital/institution
|
Nature of interest |
clinical registration trials, Registries
|
Nature of restriction |
Restricted: to execute the task for company trial
|
4. Other potential conflicts of interest?
5. Is there anything else that might influence your judgement, or might be perceived to do so?
Yes. Data safety monitoring boards of clinical trials
6. Member (current) of any kind of committee, board, WG, etc. of another scientific association with similar aims as ERA-EDTA
